iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by JTC Employer Solutions Trustee Ltd

JTC Employer Solutions Trustee Ltd increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 31.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,909 shares of the financial services provider’s stock after purchasing an additional 695 shares during the period. JTC Employer Solutions Trustee Ltd’s holdings in iShares Biotechnology ETF were worth $401,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Future Financial Wealth Managment LLC acquired a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $27,000. Pacifica Partners Inc. grew its position in iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after buying an additional 130 shares during the period. Crewe Advisors LLC increased its holdings in iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares in the last quarter. Northwest Financial Advisors acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $42,000. Finally, Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $43,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock traded down $0.93 on Wednesday, hitting $135.09. The company’s stock had a trading volume of 1,045,826 shares, compared to its average volume of 1,631,982. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The firm has a fifty day moving average price of $134.94 and a 200-day moving average price of $134.97.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.